159 related articles for article (PubMed ID: 30817774)
1. The endogenous cardiotonic steroid Marinobufagenin and decline in estimated glomerular filtration rate at follow-up in patients with arterial hypertension.
Keppel MH; Piecha G; März W; Cadamuro J; Auer S; Felder TK; Mrazek C; Oberkofler H; Trummer C; Grübler MR; Schwetz V; Verheyen N; Pandis M; Borzan V; Haschke-Becher E; Tomaschitz A; Pilz S
PLoS One; 2019; 14(2):e0212973. PubMed ID: 30817774
[TBL] [Abstract][Full Text] [Related]
2. Endogenous cardiotonic steroids in chronic renal failure.
Kolmakova EV; Haller ST; Kennedy DJ; Isachkina AN; Budny GV; Frolova EV; Piecha G; Nikitina ER; Malhotra D; Fedorova OV; Shapiro JI; Bagrov AY
Nephrol Dial Transplant; 2011 Sep; 26(9):2912-9. PubMed ID: 21292813
[TBL] [Abstract][Full Text] [Related]
3. Marinobufagenin-induced vascular fibrosis is a likely target for mineralocorticoid antagonists.
Fedorova OV; Emelianov IV; Bagrov KA; Grigorova YN; Wei W; Juhasz O; Frolova EV; Marshall CA; Lakatta EG; Konradi AO; Bagrov AY
J Hypertens; 2015 Aug; 33(8):1602-10. PubMed ID: 26136067
[TBL] [Abstract][Full Text] [Related]
4. Marinobufagenin in essential hypertension and primary aldosteronism: a cardiotonic steroid with clinical and diagnostic implications.
Tomaschitz A; Piecha G; Ritz E; Meinitzer A; Haas J; Pieske B; Wiecek A; Rus-Machan J; Toplak H; März W; Verheyen N; Gaksch M; Amrein K; Kraigher-Krainer E; Fahrleitner-Pammer A; Pilz S
Clin Exp Hypertens; 2015; 37(2):108-15. PubMed ID: 24785704
[TBL] [Abstract][Full Text] [Related]
5. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
[TBL] [Abstract][Full Text] [Related]
6. Marinobufagenin, an endogenous ligand of alpha-1 sodium pump, is a marker of congestive heart failure severity.
Fridman AI; Matveev SA; Agalakova NI; Fedorova OV; Lakatta EG; Bagrov AY
J Hypertens; 2002 Jun; 20(6):1189-94. PubMed ID: 12023690
[TBL] [Abstract][Full Text] [Related]
7. Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension.
Fedorova OV; Talan MI; Agalakova NI; Droy-Lefaix MT; Lakatta EG; Bagrov AY
Hypertension; 2003 Mar; 41(3):505-11. PubMed ID: 12623951
[TBL] [Abstract][Full Text] [Related]
8. Passive immunization against marinobufagenin attenuates renal fibrosis and improves renal function in experimental renal disease.
Haller ST; Drummond CA; Yan Y; Liu J; Tian J; Malhotra D; Shapiro JI
Am J Hypertens; 2014 Apr; 27(4):603-9. PubMed ID: 24014658
[TBL] [Abstract][Full Text] [Related]
9. Elevated Plasma Marinobufagenin, An Endogenous Cardiotonic Steroid, Is Associated With Right Ventricular Dysfunction and Nitrative Stress in Heart Failure.
Kennedy DJ; Shrestha K; Sheehey B; Li XS; Guggilam A; Wu Y; Finucan M; Gabi A; Medert CM; Westfall K; Borowski A; Fedorova O; Bagrov AY; Tang WH
Circ Heart Fail; 2015 Nov; 8(6):1068-76. PubMed ID: 26276886
[TBL] [Abstract][Full Text] [Related]
10. Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy.
Kennedy DJ; Vetteth S; Periyasamy SM; Kanj M; Fedorova L; Khouri S; Kahaleh MB; Xie Z; Malhotra D; Kolodkin NI; Lakatta EG; Fedorova OV; Bagrov AY; Shapiro JI
Hypertension; 2006 Mar; 47(3):488-95. PubMed ID: 16446397
[TBL] [Abstract][Full Text] [Related]
11. Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism.
Bagrov AY; Dmitrieva RI; Dorofeeva NA; Fedorova OV; Lopatin DA; Lakatta EG; Droy-Lefaix MT
J Hypertens; 2000 Feb; 18(2):209-15. PubMed ID: 10694190
[TBL] [Abstract][Full Text] [Related]
12. Effect of Cardiotonic Steroid Marinobufagenin on Vascular Remodeling and Cognitive Impairment in Young Dahl-S Rats.
Grigorova YN; Juhasz O; Long JM; Zernetkina VI; Hall ML; Wei W; Morrell CH; Petrashevskaya N; Morrow A; LaNasa KH; Bagrov AY; Rapp PR; Lakatta EG; Fedorova OV
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562955
[TBL] [Abstract][Full Text] [Related]
13. Association of plasma resistin with glomerular filtration rate and albuminuria in hypertensive adults.
Ellington AA; Malik AR; Klee GG; Turner ST; Rule AD; Mosley TH; Kullo IJ
Hypertension; 2007 Oct; 50(4):708-14. PubMed ID: 17785630
[TBL] [Abstract][Full Text] [Related]
14. The Cardiotonic Steroid Marinobufagenin Is a Predictor of Increased Left Ventricular Mass in Obesity: The African-PREDICT Study.
Strauss-Kruger M; Kruger R; Smith W; Gafane-Matemane LF; Mokwatsi G; Wei W; Fedorova OV; Schutte AE
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33081045
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin Attenuates Cardiac Fibrosis in Experimental Uremic Cardiomyopathy by Reducing Marinobufagenin Levels and Inhibiting Downstream Pro-Fibrotic Signaling.
Haller ST; Yan Y; Drummond CA; Xie J; Tian J; Kennedy DJ; Shilova VY; Xie Z; Liu J; Cooper CJ; Malhotra D; Shapiro JI; Fedorova OV; Bagrov AY
J Am Heart Assoc; 2016 Sep; 5(10):. PubMed ID: 27694325
[TBL] [Abstract][Full Text] [Related]
16. The cardiotonic steroid hormone marinobufagenin induces renal fibrosis: implication of epithelial-to-mesenchymal transition.
Fedorova LV; Raju V; El-Okdi N; Shidyak A; Kennedy DJ; Vetteth S; Giovannucci DR; Bagrov AY; Fedorova OV; Shapiro JI; Malhotra D
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F922-34. PubMed ID: 19176701
[TBL] [Abstract][Full Text] [Related]
17. Genetic Control of Serum Marinobufagenin in the Spontaneously Hypertensive Rat and the Relationship to Blood Pressure.
Dmitrieva RI; Cranford SM; Doris PA
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982675
[TBL] [Abstract][Full Text] [Related]
18. Changing Protein Permeability with Nephron Loss: Evidence for a Human Remnant Nephron Effect.
Willows J; Odudu A; Logan I; Sheerin N; Tomson C; Ellam T
Am J Nephrol; 2019; 50(2):152-159. PubMed ID: 31269482
[TBL] [Abstract][Full Text] [Related]
19. Single-Center Long-Term Follow-Up of Kidney Donors in Argentina (Hospital Italiano de Buenos Aires).
Mombelli CA; Giordani MC; Imperiali NC; Groppa SR; Villamil Cortez SK; Schreck CM; Rosa-Diez GJ
Transplant Proc; 2018 Mar; 50(2):418-422. PubMed ID: 29579818
[TBL] [Abstract][Full Text] [Related]
20. Coordinated shifts in Na/K-ATPase isoforms and their endogenous ligands during cardiac hypertrophy and failure in NaCl-sensitive hypertension.
Fedorova OV; Talan MI; Agalakova NI; Lakatta EG; Bagrov AY
J Hypertens; 2004 Feb; 22(2):389-97. PubMed ID: 15076199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
